Delhi-based AIIMS Ethics Committee will begin the human trial of Kovid-19 indigenously developed Kovaxin today.

It is being told that more than 1000 people have registered for human trials in the last 10 hours, the first step will be tested on 375 people, out of which 100 people can be in AIIMS.

Healthy people will be included in this test, who do not have any other disease and who have not been suffering from Kovid 19, whose age is 18 years and below 55 years.